Inscription Capital »

Myriad Genetics shares owned by Inscription Capital

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Inscription Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $144k 23k 6.15

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Spdr Series Trust State Street Spd (BIL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Wal-Mart Stores (WMT)
Chevron Corporation (CVX)
Nike CL B (NKE)

View all positions for Inscription Capital

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Charles Schwab Investment Management
AQR Capital Management
Federated Investors
Dimensional Fund Advisors
Point72 Asset Management
Vestal Point Capital

View all funds holding Myriad Genetics